A team of University of Tokyo researchers said Thursday it will begin a clinical study later this month on a vaccine for the Ebola virus, a first in Japan, with the vaccine developed using an artificially produced detoxified virus.
The new vaccine developed by Yoshihiro Kawaoka, a professor at the university’s Institute of Medical Science, and others is believed to have fewer side effects compared to those produced abroad, according to the institute.
The researchers said they aim to develop the Ebola vaccine to prevent further outbreaks of the deadly hemorrhagic fever in Africa.
Comments are closed.